Human Microbiome and its Association With Health and Diseases

Human microbiota are distinct communities of microorganisms that resides at different body niches. Exploration of the human microbiome has become a reality due to the availability of powerful metagenomics and metatranscriptomic analysis technologies. Recent advances in sequencing and bioinformatics over the past decade help provide a deep insight into the nature of the host‐microbial interactions and identification of potential deriver genes and pathways associated with human health, well‐being, and predisposition to different diseases. In the present review, we outline recent studies devoted to elucidate the possible link between the microbiota and various type of diseases. The present review also highlights the potential utilization of microbiota as a potential therapeutic option to treat a wide array of human diseases. J. Cell. Physiol. 231: 1688–1694, 2016. © 2015 Wiley Periodicals, Inc.

[1]  R. Knight,et al.  Diversity, stability and resilience of the human gut microbiota , 2012, Nature.

[2]  Rodrigo Morales,et al.  Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases , 2010, The Journal of Neuroscience.

[3]  G. Nardone,et al.  The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? , 2015, United European gastroenterology journal.

[4]  A. Fanning,et al.  Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome , 2011, The American Journal of Gastroenterology.

[5]  C. Datz,et al.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.

[6]  R. Sandler,et al.  Fusobacterium Is Associated with Colorectal Adenomas , 2013, PloS one.

[7]  M. Al-Asmakh,et al.  Microbiota and the control of blood-tissue barriers , 2015, Tissue barriers.

[8]  L. Fulton,et al.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.

[9]  C. Bode,et al.  Alcohol’s Role in Gastrointestinal Tract Disorders , 1997, Alcohol health and research world.

[10]  Ruth E Ley,et al.  Obesity and the human microbiome , 2010, Current opinion in gastroenterology.

[11]  Asit Ranjan Ghosh.  Appraisal of Microbial Evolution to Commensalism and Pathogenicity in Humans , 2013, Clinical medicine insights. Gastroenterology.

[12]  A. Iwasaki,et al.  Microbiota regulates immune defense against respiratory tract influenza A virus infection , 2011, Proceedings of the National Academy of Sciences.

[13]  D. Carvalho,et al.  Gut Microbiota: Association with NAFLD and Metabolic Disturbances , 2015, BioMed research international.

[14]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[16]  J. Laparra,et al.  Interactions of gut microbiota with functional food components and nutraceuticals. , 2010, Pharmacological research.

[17]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[18]  Chi-Hong Tseng,et al.  Molecular Analysis of Fungal Microbiota in Samples from Healthy Human Skin and Psoriatic Lesions , 2006, Journal of Clinical Microbiology.

[19]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[20]  E. Comelli,et al.  Intestinal microbiota in patients with nonalcoholic fatty liver disease , 2013, Hepatology.

[21]  Masoumeh Sikaroodi,et al.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[22]  J. Rafter,et al.  Gut microbial communities modulating brain development and function , 2012, Gut microbes.

[23]  C. Lee,et al.  Microbial community and metabolomic comparison of irritable bowel syndrome faeces , 2011, Journal of medical microbiology.

[24]  M. Fischbach,et al.  Community Health Care: Therapeutic Opportunities in the Human Microbiome , 2011, Science Translational Medicine.

[25]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[26]  Wonyong Kim,et al.  Characterization of the Fungal Microbiota (Mycobiome) in Healthy and Dandruff-Afflicted Human Scalps , 2012, PloS one.

[27]  M. Chapman,et al.  Disease to Dirt: The Biology of Microbial Amyloids , 2013, PLoS pathogens.

[28]  Richard Hansen,et al.  Microbiota of De-Novo Pediatric IBD: Increased Faecalibacterium Prausnitzii and Reduced Bacterial Diversity in Crohn's But Not in Ulcerative Colitis , 2012, The American Journal of Gastroenterology.

[29]  E. El-Omar,et al.  The fungal microbiota of de-novo paediatric inflammatory bowel disease , 2015, Microbes and infection.

[30]  J. V. van Putten,et al.  Toll‐like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms , 2010, Cellular microbiology.

[31]  Jenny Sauk,et al.  Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.

[32]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[33]  M. Blaser,et al.  The human microbiome: at the interface of health and disease , 2012, Nature Reviews Genetics.

[34]  C. Holmes.  Review: Systemic inflammation and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.

[35]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[36]  D. Beall.  Classification and Grading of Gastritis: The Updated Sydney System , 1997 .

[37]  James Versalovic,et al.  The Human Microbiome and Its Potential Importance to Pediatrics , 2012, Pediatrics.

[38]  D. Keszthelyi,et al.  Leaky gut and diabetes mellitus: what is the link? , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[39]  Jeffrey I. Gordon,et al.  Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N A Mabbott,et al.  Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium , 2013, Mucosal Immunology.

[41]  Martin Wiedmann,et al.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum , 2007, The ISME Journal.

[42]  H. Forssberg,et al.  Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.

[43]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[44]  H. Rangwala,et al.  Colonic microbiome is altered in alcoholism. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[45]  Jerrold R. Turner,et al.  Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.

[46]  M. Gaudric,et al.  [Bacterial flora in gastric juice taken at endoscopy in 93 normal subjects]. , 1986, Pathologie-biologie.

[47]  A. Zhernakova,et al.  Rapidly expanding knowledge on the role of the gut microbiome in health and disease. , 2014, Biochimica et biophysica acta.

[48]  P. Lipke,et al.  Functional amyloid formation by Streptococcus mutans. , 2012, Microbiology.

[49]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[50]  Ian D Wilson,et al.  Drugs, bugs, and personalized medicine: Pharmacometabonomics enters the ring , 2009, Proceedings of the National Academy of Sciences.

[51]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[52]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[53]  V. Tremaroli,et al.  The gut microbiota regulates bone mass in mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  C. McClain,et al.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. , 2008, Alcohol.

[55]  G. Schmidt,et al.  Gastrointestinal transit of solid-liquid meal in chronic alcoholics , 1991, Digestive Diseases and Sciences.

[56]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[57]  Herbert W Virgin,et al.  The Virome in Mammalian Physiology and Disease , 2014, Cell.

[58]  J. Neu.  The Human Microbiome and Its Potential Importance to Pediatrics , 2012 .

[59]  L. Bodea,et al.  Neurodegeneration by Activation of the Microglial Complement–Phagosome Pathway , 2014, The Journal of Neuroscience.

[60]  Myung-Shik Lee,et al.  Gut Microbiota and Metabolic Disorders , 2015, Diabetes & metabolism journal.

[61]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[62]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[63]  P. Hylemon,et al.  Linkage of gut microbiome with cognition in hepatic encephalopathy. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[64]  D. Sinderen,et al.  Gut microbiota composition correlates with diet and health in the elderly , 2012, Nature.

[65]  Shu-sen Zheng,et al.  Assessment of the Fecal Lactobacilli Population in Patients with Hepatitis B Virus-Related Decompensated Cirrhosis and Hepatitis B Cirrhosis Treated with Liver Transplant , 2011, Microbial Ecology.

[66]  M. Hibberd,et al.  Intestinal Microbiota Regulate Xenobiotic Metabolism in the Liver , 2009, PloS one.

[67]  Janet K. Jansson,et al.  Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. , 2009, Journal of medical microbiology.

[68]  Rustem F. Ismagilov,et al.  Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness , 2014, Nature.

[69]  Manolito Torralba,et al.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease , 2011, Hepatology.

[70]  Blaise R. Boles,et al.  Microbial amyloids--functions and interactions within the host. , 2013, Current opinion in microbiology.

[71]  M. Veldhoen,et al.  Epithelial barrier biology: good fences make good neighbours , 2012, Immunology.

[72]  Joshua LaBaer,et al.  Reduced Incidence of Prevotella and Other Fermenters in Intestinal Microflora of Autistic Children , 2013, PloS one.

[73]  C. Bode,et al.  Jejunal microflora in patients with chronic alcohol abuse. , 1984, Hepato-gastroenterology.

[74]  Jacques Schrenzel,et al.  Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice , 2011, Diabetes.

[75]  Baoli Zhu,et al.  Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.

[76]  M. Teixeira,et al.  Commensal microbiota is fundamental for the development of inflammatory pain , 2008, Proceedings of the National Academy of Sciences.

[77]  S. Kaufmann,et al.  Notch signaling is activated by TLR stimulation and regulates macrophage functions , 2008, European journal of immunology.

[78]  M. Blaser.  Harnessing the power of the human microbiome , 2010, Proceedings of the National Academy of Sciences.

[79]  H. Flint,et al.  Rates of production and utilization of lactate by microbial communities from the human colon. , 2011, FEMS microbiology ecology.

[80]  Wei Xu,et al.  Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection , 2011, Microbial Ecology.

[81]  U. Römling,et al.  Expression of cellulose and curli fimbriae by Escherichia coli isolated from the gastrointestinal tract. , 2005, Journal of medical microbiology.

[82]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[83]  Belgin Dogan,et al.  Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.

[84]  Marcus J Claesson,et al.  An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota , 2011, Gut.

[85]  Lu Wang,et al.  The NIH Human Microbiome Project. , 2009, Genome research.

[86]  Simon A. Jones,et al.  Soluble TLR2 Reduces Inflammation without Compromising Bacterial Clearance by Disrupting TLR2 Triggering1 , 2009, The Journal of Immunology.

[87]  Haifeng Lu,et al.  Changes of Fecal Bifidobacterium Species in Adult Patients with Hepatitis B Virus-Induced Chronic Liver Disease , 2011, Microbial Ecology.

[88]  J. Zweier,et al.  Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.

[89]  James Versalovic,et al.  Human microbiome in health and disease. , 2012, Annual review of pathology.

[90]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[91]  James Versalovic,et al.  Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. , 2009, Gastroenterology.

[92]  R. Thurman,et al.  Antibiotics prevent liver injury in rats following long-term exposure to ethanol. , 1995, Gastroenterology.

[93]  J. Petrosino,et al.  Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders , 2013, Cell.

[94]  D. Farfara,et al.  Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application , 2010, Mediators of inflammation.

[95]  Agata Korecka,et al.  The gut microbiome: scourge, sentinel or spectator? , 2012, Journal of oral microbiology.

[96]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[97]  D. Shawcross,et al.  Systemic inflammation and ammonia in hepatic encephalopathy , 2012, Metabolic Brain Disease.

[98]  M. Leja,et al.  Helicobacter pylori infection and nonmalignant diseases , 2017, Helicobacter.

[99]  E. Kuipers,et al.  Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn? , 2009, The American Journal of Gastroenterology.

[100]  Sebastian Tims,et al.  Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.

[101]  S. Pettersson,et al.  The Gut Microbiota and Developmental Programming of the Testis in Mice , 2014, PloS one.

[102]  P. François,et al.  Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity , 2014, The ISME Journal.

[103]  R. Friedland.  Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. , 2015, Journal of Alzheimer's disease : JAD.

[104]  C. Hofmann,et al.  Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense , 2012, Hepatology.

[105]  Vincent Wai-Sun Wong,et al.  Bacterial Microbiota Profiling in Gastritis without Helicobacter pylori Infection or Non-Steroidal Anti-Inflammatory Drug Use , 2009, PloS one.

[106]  W. Weichert,et al.  Fungi and inflammatory bowel diseases: Alterations of composition and diversity , 2008, Scandinavian journal of gastroenterology.

[107]  E. Dempsey,et al.  Microbial Composition of Human Appendices from Patients following Appendectomy , 2013, mBio.